B44.1

Case	Control
153	460052

Location	SNP	Gene	Ref>Alt	Alt in Case	Alt in Control	Chi-square	P-value	Odds Ratio
chr2:21233972	rs533617	APOB	T>C	32	37424	33.26	8.06e-09	2.799
chr9:77305469	rs1410228	RORB	A>G	73	125142	29.61	5.285e-08	2.037
chr7:28944159	rs10486599	-	C>T	25	28400	27.54	1.541e-07	2.845
chr12:23209701	rs140297038	-	A>G	23	25044	27.53	1.546e-07	2.953
chr13:27944456	rs76660294	-	C>T	29	35931	26.33	2.879e-07	2.618
chr1:170311814	rs61828015	-	A>G	16	14941	25.67	4.04e-07	3.397
chr13:27899075	rs61944015	-	C>A	28	34610	25.63	4.138e-07	2.623
chr6:50609600	rs114533999	-	T>C	13	10988	24.9	6.037e-07	3.731
chr16:55908870	rs72810510	CES5A	C>T	15	13929	24.35	8.048e-07	3.412
chr19:41354458	rs28399442	AC008537.1	C>A	19	20281	23.82	1.059e-06	3.002
chr6:126473631	rs1411585	TRMT11	G>T	15	14118	23.8	1.071e-06	3.37
chr17:43190322	rs72832860	PLCD3	T>C	15	14125	23.75	1.098e-06	3.366
chr4:168884458	rs76680543	-	C>T	19	20264	23.65	1.155e-06	2.991
chr6:149533965	rs35000313	-	TC>T	21	23579	23.56	1.21e-06	2.852
chr4:97078713	rs28433813	-	A>C	17	17078	23.33	1.364e-06	3.132
chr18:22100922	rs79385303	-	C>T	23	27380	22.82	1.776e-06	2.7
chr6:10536236	rs80046324	GCNT2	C>T	22	25661	22.82	1.777e-06	2.753
chr3:159869997	rs79355792	-	G>A	20	22310	22.78	1.817e-06	2.868
chr3:124743805	rs116515732	HEG1	G>A	20	22400	22.54	2.06e-06	2.853
chr11:105627852	rs78436406	GRIA4	T>G	15	14658	22.13	2.547e-06	3.241
chr2:21233972	rs533617	APOB	T>C	32	36228	34.17	5.039e-09	2.842
chr9:77305469	rs1410228	RORB	A>G	68	110114	30.94	2.668e-08	2.113
chr13:27944456	rs76660294	-	C>T	29	33867	28.78	8.1e-08	2.731
chr12:23209701	rs140297038	-	A>G	23	24694	27.18	1.855e-07	2.939
chr17:43190322	rs72832860	PLCD3	T>C	15	13166	26.03	3.361e-07	3.545
chr13:27899075	rs61944015	-	C>A	28	33927	25.62	4.164e-07	2.627
chr6:126473631	rs1411585	TRMT11	G>T	15	13311	25.55	4.32e-07	3.508
chr7:28944159	rs10486599	-	C>T	23	25524	25.45	4.549e-07	2.846
chr1:170311814	rs61828015	-	A>G	16	14722	25.41	4.644e-07	3.382
chr6:50609600	rs114533999	-	T>C	13	10767	24.89	6.068e-07	3.734
chr18:22100922	rs79385303	-	C>T	22	24159	24.87	6.12e-07	2.871
chr16:55908870	rs72810510	CES5A	C>T	15	13512	24.8	6.368e-07	3.45
chr4:168884458	rs76680543	-	C>T	19	19911	23.52	1.238e-06	2.986
chr6:149533965	rs35000313	-	TC>T	21	23232	23.29	1.39e-06	2.84
chr10:73946588	rs7088203	ASCC1	A>G	12	9889	23.25	1.422e-06	3.753
chr2:4033205	rs115142829	-	T>C	17	17087	22.91	1.696e-06	3.107
chr4:97078713	rs28433813	-	A>C	17	16894	22.89	1.713e-06	3.105
chr3:159869997	rs79355792	-	G>A	20	21952	22.58	2.017e-06	2.859
chr6:10536236	rs80046324	GCNT2	C>T	22	25297	22.55	2.048e-06	2.742
chr11:73768553	rs12419308	C2CD3	C>T	20	22232	22.29	2.344e-06	2.842

Location

SNP

Gene

Ref>Alt

Alt in Case

Alt in Control

Chi-square

P-value

Odds Ratio

chr2:21233972

rs533617

APOB

T>C

32

37424

33.26

8.06e-09

2.799

chr9:77305469

rs1410228

RORB

A>G

73

125142

29.61

5.285e-08

2.037

chr7:28944159

rs10486599

-

C>T

25

28400

27.54

1.541e-07

2.845

chr12:23209701

rs140297038

-

A>G

23

25044

27.53

1.546e-07

2.953

chr13:27944456

rs76660294

-

C>T

29

35931

26.33

2.879e-07

2.618

chr1:170311814

rs61828015

-

A>G

16

14941

25.67

4.04e-07

3.397

chr13:27899075

rs61944015

-

C>A

28

34610

25.63

4.138e-07

2.623

chr6:50609600

rs114533999

-

T>C

13

10988

24.9

6.037e-07

3.731

chr16:55908870

rs72810510

CES5A

C>T

15

13929

24.35

8.048e-07

3.412

chr19:41354458

rs28399442

AC008537.1

C>A

19

20281

23.82

1.059e-06

3.002

chr6:126473631

rs1411585

TRMT11

G>T

15

14118

23.8

1.071e-06

3.37

chr17:43190322

rs72832860

PLCD3

T>C

15

14125

23.75

1.098e-06

3.366

chr4:168884458

rs76680543

-

C>T

19

20264

23.65

1.155e-06

2.991

chr6:149533965

rs35000313

-

TC>T

21

23579

23.56

1.21e-06

2.852

chr4:97078713

rs28433813

-

A>C

17

17078

23.33

1.364e-06

3.132

chr18:22100922

rs79385303

-

C>T

23

27380

22.82

1.776e-06

2.7

chr6:10536236

rs80046324

GCNT2

C>T

22

25661

22.82

1.777e-06

2.753

chr3:159869997

rs79355792

-

G>A

20

22310

22.78

1.817e-06

2.868

chr3:124743805

rs116515732

HEG1

G>A

20

22400

22.54

2.06e-06

2.853

chr11:105627852

rs78436406

GRIA4

T>G

15

14658

22.13

2.547e-06

3.241

chr2:21233972

rs533617

APOB

T>C

32

36228

34.17

5.039e-09

2.842

chr9:77305469

rs1410228

RORB

A>G

68

110114

30.94

2.668e-08

2.113

chr13:27944456

rs76660294

-

C>T

29

33867

28.78

8.1e-08

2.731

chr12:23209701

rs140297038

-

A>G

23

24694

27.18

1.855e-07

2.939

chr17:43190322

rs72832860

PLCD3

T>C

15

13166

26.03

3.361e-07

3.545

chr13:27899075

rs61944015

-

C>A

28

33927

25.62

4.164e-07

2.627

chr6:126473631

rs1411585

TRMT11

G>T

15

13311

25.55

4.32e-07

3.508

chr7:28944159

rs10486599

-

C>T

23

25524

25.45

4.549e-07

2.846

chr1:170311814

rs61828015

-

A>G

16

14722

25.41

4.644e-07

3.382

chr6:50609600

rs114533999

-

T>C

13

10767

24.89

6.068e-07

3.734

chr18:22100922

rs79385303

-

C>T

22

24159

24.87

6.12e-07

2.871

chr16:55908870

rs72810510

CES5A

C>T

15

13512

24.8

6.368e-07

3.45

chr4:168884458

rs76680543

-

C>T

19

19911

23.52

1.238e-06

2.986

chr6:149533965

rs35000313

-

TC>T

21

23232

23.29

1.39e-06

2.84

chr10:73946588

rs7088203

ASCC1

A>G

12

9889

23.25

1.422e-06

3.753

chr2:4033205

rs115142829

-

T>C

17

17087

22.91

1.696e-06

3.107

chr4:97078713

rs28433813

-

A>C

17

16894

22.89

1.713e-06

3.105

chr3:159869997

rs79355792

-

G>A

20

21952

22.58

2.017e-06

2.859

chr6:10536236

rs80046324

GCNT2

C>T

22

25297

22.55

2.048e-06

2.742

chr11:73768553

rs12419308

C2CD3

C>T

20

22232

22.29

2.344e-06

2.842

ID	Name	Top Correlation
HP: 0000118	Phenotypic abnormality	0/20
HP: 0000951	Abnormality of the skin	0/20
HP: 0001574	Abnormality of the integument	0/20
HP: 0001581	Recurrent skin infections	0/20
HP: 0002086	Abnormality of the respiratory system	0/20
HP: 0002088	Abnormal lung morphology	0/20
HP: 0002105	Hemoptysis	0/20
HP: 0002113	Pulmonary infiltrates	0/20
HP: 0002715	Abnormality of the immune system	0/20
HP: 0002719	Recurrent infections	0/20
HP: 0002728	Chronic mucocutaneous candidiasis	0/20
HP: 0002795	Functional respiratory abnormality	0/20
HP: 0002841	Recurrent fungal infections	0/20
HP: 0010978	Abnormality of immune system physiology	0/20
HP: 0011122	Abnormality of skin physiology	0/20
HP: 0011123	Inflammatory abnormality of the skin	0/20
HP: 0011370	Recurrent cutaneous fungal infections	0/20
HP: 0012204	Recurrent vulvovaginal candidiasis	0/20
HP: 0012252	Abnormal respiratory system morphology	0/20
HP: 0012647	Abnormal inflammatory response	0/20
HP: 0012649	Increased inflammatory response	0/20
HP: 0012735	Cough	0/20
HP: 0020100	Unusual fungal infection	0/20
HP: 0020101	Invasive fungal infection	0/20
HP: 0020102	Pneumocystis jirovecii pneumonia	0/20
HP: 0020103	Invasive pulmonary aspergillosis	0/20
HP: 0031245	Productive cough	0/20
HP: 0031690	Opportunistic infection	0/20
HP: 0031983	Abnormal pulmonary thoracic imaging finding	0/20
HP: 0032016	Abnormal sputum	0/20
HP: 0032101	Unusual infection	0/20
HP: 0032172	Air crescent sign	0/20
HP: 0032174	Tree-in-bud pattern	0/20
HP: 0032255	Opportunistic fungal infection	0/20

Other pulmonary aspergillosis

B44.1

Case/Control GWAS ^ⓘ

Links

Statistics

Top SNP Information

Associated Phenotypes ^ⓘ

Other pulmonary aspergillosis

B44.1

Case/Control GWAS ⓘ

Links

Statistics

Top SNP Information Show Table

Associated Phenotypes ⓘ Shared SNP phenotypes No shared SNP phenotypes

Case/Control GWAS ^ⓘ

Top SNP Information

Associated Phenotypes ^ⓘ